Regulation of dopamine and serotonin synthesis by acute administration of cocaine

Synapse
M P Galloway

Abstract

Because cocaine effectively increases extracellular levels of both dopamine (DA) and serotonin (5HT), it might be expected that this agent would inhibit transmitter biosynthesis in these monoamine neurons by activation of autoregulatory feedback pathways. This possibility was tested by measuring the effect of cocaine on 3,4-dihydroxyphenylalanine accumulation (DA synthesis) and 5-hydroxytryptophan accumulation (5HT synthesis) in vivo and in vitro after inhibition of aromatic amino acid decarboxylase with NSD-1015. In vivo, cocaine suppressed both DA and 5HT synthesis in a dose-dependent (10-60 mumols/kg, i.p.) and time-dependent fashion (maximum 60 min after administration, recovery by 120-150 min). Inhibition of DA and 5HT synthesis ranged from 35% to 60% depending on the brain region and was apparent in dopaminergic fields such as the medial prefrontal cortex, nucleus accumbens, piriform cortex, striatum, and in noradrenergic fields, such as the hippocampus and temporal cortex. Inhibition of DA, but not 5HT, synthesis was blocked by the D2 antagonist sulpiride in brain areas containing DA nerve terminals. Procaine (30 mumols/kg) did not inhibit DA or 5HT synthesis and prior treatment with reserpine diminished the effectivenes...Continue Reading

References

Dec 29, 1976·Naunyn-Schmiedeberg's Archives of Pharmacology·J R Walters, R H Roth
Nov 1, 1979·Pharmacology, Biochemistry, and Behavior·W H LynessK E Moore
Oct 1, 1986·Pharmacology, Biochemistry, and Behavior·F L SmithW H Lyness
May 1, 1986·Pharmacology, Biochemistry, and Behavior·N E GoedersJ E Smith
Jul 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·G Di Chiara, A Imperato
Feb 1, 1987·Pharmacology, Biochemistry, and Behavior·D K Pitts, J Marwah
May 1, 1988·Trends in Pharmacological Sciences·J M Lakoski, K A Cunningham
Oct 1, 1988·Trends in Pharmacological Sciences·A M Broadhurst, M Briley
Aug 9, 1988·Brain Research·S E Robinson, K L Hambrecht
Dec 1, 1988·Trends in Pharmacological Sciences·M P Galloway
Apr 13, 1988·European Journal of Pharmacology·K A Cunningham, J M Lakoski
Nov 12, 1986·European Journal of Pharmacology·D K Pitts, J Marwah
Jul 1, 1985·Journal of Neurochemistry·C MissaleI Hanbauer
Jan 1, 1984·Annals of the New York Academy of Sciences·R H Roth
Aug 19, 1983·Science·N E Goeders, J E Smith
May 1, 1980·Pharmacology, Biochemistry, and Behavior·D C RobertsH C Fibiger
Jun 1, 1980·Pharmacology, Biochemistry, and Behavior·W H LynessK E Moore

❮ Previous
Next ❯

Citations

May 1, 1995·Psychopharmacology·S C AronsonL H Price
Apr 1, 1992·Integrative Physiological and Behavioral Science : the Official Journal of the Pavlovian Society·X B QianR W Rockhold
Dec 21, 2000·Current Psychiatry Reports·G O'Leary, R D Weiss
Jul 23, 1991·European Journal of Pharmacology·S Benloucif, M P Galloway
Oct 1, 1992·Pharmacology, Biochemistry, and Behavior·M G Hadfield, C Milio
Mar 1, 1992·Pharmacology, Biochemistry, and Behavior·N A DarmaniR A Glennon
Jul 1, 1993·Pharmacology, Biochemistry, and Behavior·G R KingE H Ellinwood
Jun 23, 1995·Neuroscience Letters·M H Baumann, R B Rothman
Jan 1, 1994·Brain Research Bulletin·T M CabreraG Battaglia
Jun 1, 1996·Drug and Alcohol Dependence·S L BatkiR T Jones
Mar 5, 2004·Neuropharmacology·Eugene D FestaVanya Quinones-Jenab
Dec 23, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Patricia A BroderickYueping Zhou
Jan 31, 2004·Progress in Neuro-psychopharmacology & Biological Psychiatry·Rodrigo Machado-VieiraJair C Soares
Dec 30, 1996·European Journal of Pharmacology·C S Norton, M P Galloway
Nov 1, 1996·Pharmacology, Biochemistry, and Behavior·N A Darmani, S L Reeves
Oct 2, 2002·Journal of Neurochemistry·Kamisha L Johnson-DavisKristen A Keefe
Jan 1, 1993·Pharmacology & Toxicology·N L Benowitz
Jun 28, 1992·Annals of the New York Academy of Sciences·K A CunninghamN E Goeders
Aug 21, 2010·Theoretical Biology & Medical Modelling·Janet BestMichael Reed
Jun 7, 2013·PloS One·Eirik SøvikAndrew B Barron
Jan 29, 2011·Clinical and Experimental Hypertension : CHE·Daniel ElyRolando Ramirez
Jan 22, 2013·Journal of Neuroscience Research·Venkata Siva Sai Sujith SajjaPamela VandeVord

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.